Xenetic Biosciences, Inc. (NASDAQ:XBIO)

BRIEF

published on 12/17/2024 at 15:20, 4 days 3 hours ago

Xenetic Biosciences prolonge son accord de recherche avec l'Université de Virginie

Immuno-oncologie Traitement Du Cancer Biosciences Xénétiques Plateforme DNase Université De Virginie
BRIEF

published on 12/17/2024 at 15:20, 4 days 3 hours ago

Xenetic Biosciences Extends Research Agreement with University of Virginia

Xenetic Biosciences University Of Virginia Cancer Treatment DNase Platform Immune-oncology
PRESS RELEASE

published on 12/17/2024 at 15:15, 4 days 3 hours ago

Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment
Xenetic extends Research Agreement with University of Virginia for DNase-Based oncology platform. Dr. Reid Bissonnette discusses the advancement of innovative immune-oncology technologies

University Of Virginia Xenetic Research Agreement DNase-Based Oncology Platform
BRIEF

published on 12/16/2024 at 15:05, 5 days 3 hours ago

Xenetic Biosciences prolonge son accord de recherche avec l'UVA pour la plateforme d'oncologie DNase

Immunothérapie Biosciences Xénétiques Oncologie DNase Université De Virginie Les Filets
BRIEF

published on 12/16/2024 at 15:05, 5 days 3 hours ago

Xenetic Biosciences Extends Research Agreement with UVA for DNase Oncology Platform

Xenetic Biosciences University Of Virginia Immunotherapy DNase Oncology NETs
PRESS RELEASE

published on 12/16/2024 at 15:00, 5 days 3 hours ago

Xenetic Biosciences, Inc. Extends Research Agreement with the University of Virginia for the Advancement of its DNase-Based Oncology Platform
Xenetic Biosciences extends Research Funding Agreement with UVA to develop systemic DNase program targeting NETs to improve cancer therapy outcomes

Xenetic Biosciences DNase Program Cancer Therapy Immunotherapy NETs
BRIEF

published on 12/05/2024 at 14:50, 16 days 4 hours ago

Xenetic Biosciences s'associe à PeriNess pour les services d'essais cliniques

Essais Cliniques Oncologie Biosciences Xénétiques ADNase I PeriNess Ltée.
BRIEF

published on 12/05/2024 at 14:50, 16 days 4 hours ago

Xenetic Biosciences Partners with PeriNess for Clinical Trial Services

Xenetic Biosciences Clinical Trials Oncology DNase I PeriNess Ltd.
PRESS RELEASE

published on 12/05/2024 at 14:45, 16 days 4 hours ago

Xenetic Biosciences, Inc. Enters into Clinical Trial Services Agreement with PeriNess Ltd. to Accelerate Development of DNase I Oncology Program
Xenetic Biosciences partners with PeriNess to advance clinical proof-of-concept studies for systemic DNase I treatment in pancreatic and colorectal cancers. Collaboration aims to leverage expertize and improve therapeutic responses

Xenetic Biosciences Clinical Development Pancreatic Cancer PeriNess Systemic DNase I
BRIEF

published on 11/22/2024 at 15:20, 29 days 3 hours ago

Xenetic Biosciences partage ses connaissances sur l'efficacité de la DNase I dans le traitement du cancer

Traitement Du Cancer Biosciences Xénétiques Données Précliniques ADNase I Blocage Du Point De Contrôle Immunitaire

1 2 ... 5

Published on 12/21/2024 at 01:30, 17 hours 24 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 24 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 49 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 18 hours 54 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 24 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 18 hours 2 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 9 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 43 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 23 hours 58 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 6 hours 36 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 6 hours 36 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News